Literature DB >> 23404430

[PI-RADS classification: structured reporting for MRI of the prostate].

M Röthke1, D Blondin, H-P Schlemmer, T Franiel.   

Abstract

PURPOSE: To flesh out the ESUR guidelines for the standardized interpretation of multiparametric magnetic resonance imaging (mMRI) for the detection of prostate cancer and to present a graphic reporting scheme for improved communication of findings to urologists.
MATERIALS AND METHODS: The ESUR has recently published a structured reporting system for mMRI of the prostate (PI-RADS). This system involves the use of 5-point Likert scales for grading the findings obtained with different MRI techniques. The mMRI includes T2-weighted MRI, diffusion-weighted imaging, dynamic contrast-enhanced MRI, and MR spectroscopy. In a first step, the fundamentals of technical implementation were determined by consensus, taking into account in particular the German-speaking community. Then, representative images were selected by consensus on the basis of examinations of the three institutions. In addition, scoring intervals for an aggregated PI-RADS score were determined in consensus.
RESULTS: The multiparametric methods were discussed critically with regard to implementation and the current status. Criteria used for grading mMRI findings with the PI-RADS classification were concretized by succinct examples. Using the consensus table for aggregated scoring in a clinical setting, a diagnosis of suspected prostate cancer should be made if the PI-RADS score is 4 or higher (≥ 10 points if 3 techniques are used or ≥ 13 points if 4 techniques are used). Finally, a graphic scheme was developed for communicating mMRI prostate findings.
CONCLUSION: Structured reporting according to the ESUR guidelines contributes to quality assurance by standardizing prostate mMRI, and it facilities the communication of findings to urologists. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23404430     DOI: 10.1055/s-0032-1330270

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  38 in total

1.  Multiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameter.

Authors:  Stephan H Polanec; Katja Pinker-Domenig; Peter Brader; Dietmar Georg; Shahrokh Shariat; Claudio Spick; Martin Susani; Thomas H Helbich; Pascal A Baltzer
Journal:  World J Urol       Date:  2015-09-25       Impact factor: 4.226

2.  Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.

Authors:  M C Roethke; T H Kuru; S Schultze; D Tichy; A Kopp-Schneider; M Fenchel; H-P Schlemmer; B A Hadaschik
Journal:  Eur Radiol       Date:  2013-10-03       Impact factor: 5.315

3.  Intra- and interreader reproducibility of PI-RADSv2: A multireader study.

Authors:  Clayton P Smith; Stephanie A Harmon; Tristan Barrett; Leonardo K Bittencourt; Yan Mee Law; Haytham Shebel; Julie Y An; Marcin Czarniecki; Sherif Mehralivand; Mehmet Coskun; Bradford J Wood; Peter A Pinto; Joanna H Shih; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2018-12-21       Impact factor: 4.813

4.  The diagnostic value of PI-RADS V1 and V2 using multiparametric MRI in transition zone prostate clinical cancer.

Authors:  Ximing Wang; Jie Bao; Xiaoxia Ping; Chunhong Hu; Jianquan Hou; Fenglin Dong; Lingchuan Guo
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

5.  Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.

Authors:  Rossano Girometti; Martina Pancot; Marco Andrea Signor; Martina Urbani; Luca Balestreri; Chiara Zuiani
Journal:  Radiol Med       Date:  2018-05-12       Impact factor: 3.469

Review 6.  [Prostate gland - what would urologists like to know from radiologists?]

Authors:  U B Liehr; D Baumunk; S Blaschke; F Fischbach; B Friebe; F König; A Lemke; P Mittelstädt; M Pech; M Porsch; J Ricke; D Schindele; S Siedentopf; J J Wendler; M Schostak
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

7.  Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?

Authors:  L Schimmöller; M Quentin; D Blondin; F Dietzel; A Hiester; C Schleich; C Thomas; R Rabenalt; H E Gabbert; P Albers; G Antoch; C Arsov
Journal:  Eur Radiol       Date:  2016-02-26       Impact factor: 5.315

Review 8.  [Focal therapy for prostate cancer in Germany - 2014 status].

Authors:  A Roosen; R Ganzer; B Hadaschik; J Köllermann; A Blana; T Henkel; A-B Liehr; D Baumunk; S Machtens; G Salomon; L Sentker; U Witsch; K U Köhrmann; M Schostak
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

9.  Novel application of three-dimensional shear wave elastography in the detection of clinically significant prostate cancer.

Authors:  Sunao Shoji; Akio Hashimoto; Tomoya Nakamura; Shinichiro Hiraiwa; Haruhiro Sato; Yoshinobu Sato; Takuma Tajiri; Akira Miyajima
Journal:  Biomed Rep       Date:  2018-02-07

10.  [Prostate cancer].

Authors:  T Franiel; N Eckardt; M Waginger; M Horstmann
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.